Effects of dextroamphetamine on depression and fatigue in men with HIV: A double-blind, placebo-controlled trial

Journal of Clinical Psychiatry

Volumn 61, Issue 6, 2000, Pages 436-440

  Wagner, Glenn J ^a,b   Rabkin, Richard ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMPHETAMINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FATIGUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033947427     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0608     Document Type: Article

References (30)

1. Rabkin JG, Wagner G, Rabkin R. Sertraline effects on mood and immune status in patients with major depression and HIV illness: an open trial. J Clin Psychiatry 1994;55:433-439
2. Rabkin JG, Wagner GJ, Rabkin R. Fluoxetine treatment for depression in patients with HIV/AIDS: a randomized placebo-controlled trial. Am J Psychiatry 1999;156:101-107
3. Rabkin JG, Rabkin R, Harrison W, et al. Effects of imipramine on mood and immune status in depressed patients with HIV illness. Am J Psychiatry 1994;151:516-523
4. Levine S, Anderson D, Bystritsky A, et al. A report of eight HIV-seropositive patients with major depression responding to fluoxetine. J AIDS 1990;3:1074-1077
5. Darko DF, McCutchan JA, Kripke DF, et al. Fatigue, sleep disturbance, disability and indices of progression of HIV infection. Am J Psychiatry 1992;149:514-520
6. Holmes VF, Fernandez F, Levy JK. Psychostimulant response in AIDS-related complex patients. J Clin Psychiatry 1989;50:5-8
7. Fernandez F, Levy JL, Galizzi H. Response of HIV-related depression to psychostimulants: case reports. Hosp Community Psychiatry 1988;39: 628-631
8. Angrist B, d'Hollosy M, Sanfilipo M. Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment. J Clin Psychopharmacol 1992;2:268-272
9. Wagner G, Rabkin JG, Rabkin R. Dextroamphetamine as a treatment for depression and low energy in AIDS patients: a pilot study. J Psychosom Res 1997;42:113-116
10. Satel SL, Nelson JC. Stimulants in the treatment of depression: a critical overview. J Clin Psychiatry 1989;50:241-249
11. Nelson JC. Psychostimulants in the treatment of depression. Prim Psychiatry 1995;2:26-27
12. Stoll AL, Pillay SS, Diamond L, et al. Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series. J Clin Psychiatry 1996;57:72-76
13. Wallace AE, Kofoed LL, West AN. Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients. Am J Psychiatry 1995;152:929-931
14. Frierson RL, Wey JJ, Tabler JB. Psychostimulants for depression in medically ill. Am Fam Physician 1991;43:163-170
15. Masand P, Pickett P, Murray GB. Psychostimulants for secondary depression in medical illness. Psychosomatics 1991;32:203-208
16. Wilbur DL, MacLean AR, Allen EV. Clinical observations on the effect of benzedrine sulfate. JAMA 1937;109:549-554
17. Fernandez F, Adams F, Holmes VF. Methylphenidate for depressive disorders in cancer patients. Psychosomatics 1987;28:455-462
18. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-IV (SCID). New York, NY: Biometric Research, New York State Psychiatric Institute; 1994
19. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296
20. Derogatis LR, Melisaratos M. The Brief Symptom Inventory: an introductory report. Psychol Med 1983;13:595-605
21. Beck AT, Weissman A, Lester D, et al. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 1974;42:861-865
22. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993;37:147-153
23. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
24. Army Individual Test Battery. Manual of Directions and Scoring. Washington, DC: War Department, Adjutant General's Office; 1944
25. Wechsler D. Wechsler Adult Intelligence Scales-Revised. New York, NY: Psychological Corp; 1981
26. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993;29: 321-326
27. Spitzer WO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients: a concise QL-Index for use by physicians. J Chronic Dis 1981;34:585-597
28. Schag CC, Heinrich RL, Ganz PA, Karnofsky Performance Status revisited: reliability, validity, and guidelines. J Clin Oncol 1984;2:187-193
29. Rabkin JG, Wagner G, Rabkin R. Testosterone therapy for HIV+ men with and without hypogonadism. J Clin Psychopharmacol 1999;19:19-27
30. Rabkin JG, Ferrando SJ, Wagner GJ, et al. DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology 2000;25:53-68